Risk of Post-Transplant De Novo Donor Specific Antibodies in Patients Receiving Transfusions Perioperatively

被引：0
|
作者：
Mahoney, I. [1 ]
Young, A. [1 ]
Shekiladze, N. [2 ]
Morris, A. [3 ]
Gupta, D. [3 ]
Bhatt, K. [3 ]
Laskar, S. [3 ]
Smith, A. [3 ]
Vega, J. [4 ]
Cole, R. T. [3 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
[2] Mem Hosp, Savannah, GA USA
[3] Emory Univ, Sch Med, Cardiol, Atlanta, GA USA
[4] Emory Univ, Sch Med, Cardiothorac Surg, Atlanta, GA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2018年 / 37卷 / 04期
关键词：
D O I：
10.1016/j.healun.2018.01.1099
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1096
引用
收藏
页码：S423 / S424
页数：2
相关论文
共 50 条
  • [31] De Novo Donor Specific Antibodies in Pediatric Renal Transplant Recipients: Response to Therapy
    Tsai, E.
    Tzeng, J.
    Gjertson, D.
    Ettenger, R.
    Reed, E.
    TRANSPLANTATION, 2014, 98 : 443 - 443
  • [32] De Novo Donor-Specific HLA Antibodies: Biomarkers of Pancreas Transplant Failure
    Mittal, S.
    Page, S. L.
    Friend, P. J.
    Sharples, E. J.
    Fuggle, S. V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (07) : 1664 - 1671
  • [33] Does the Number of Donor Specific Antibodies Crossed at the Time of Heart Transplant Impact Post-Transplant Outcome?
    Kobashigawa, J.
    Kittleson, M.
    Kransdorf, E.
    Welton, M.
    Jamero, G.
    Kanungo, A.
    Lee, M.
    Bhatnagar, N.
    Stern, L.
    Nikolova, A.
    Czer, L.
    Esmailian, F.
    Patel, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S356 - S357
  • [34] TREATMENT OF POST-TRANSPLANT DENOVO HLA DONOR SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENT IN THE ABSENCE OF REJECTION
    Mujtaba, Muhammad A.
    Gamilla-Crudo, Ann
    Aleter, Omer
    Noriega, Ramon
    Ramirez, Regina
    HUMAN IMMUNOLOGY, 2017, 78 : 180 - 180
  • [35] Microcirculation Injury Is Predictive of Graft Loss in Renal Transplant Patients with De Novo Donor-Specific Antibodies
    de Kort, H.
    Willicombe, M.
    Brookes, P.
    Dominy, K. M.
    Santos-Nunez, E.
    Galliford, J. W.
    Taube, D.
    McLean, A. G.
    Cook, T. H.
    Roufosse, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 43 - 43
  • [36] Post-transplant Diabetes de NOVO (NODAT) in a Paraguayan Kidney Transplant Population: Prevalence and Risk Factors
    Acosta, Juan
    Martinez, Adriana C.
    Jara, Pablo
    Orue, Maria G.
    Mayor, Maria M.
    Benitez, Alba L.
    del Carmen Romero, Maria
    Ayala, Roger A.
    TRANSPLANTATION, 2022, 106 (09) : S546 - S546
  • [37] Post-transplant de novo anti-HLA donor specific antibodies may contribute to poor graft function after haploidentical haematopoietic stem cell transplantation
    Ji, Xinyu
    Yang, Luxin
    Lai, Xiaoyu
    Ye, Yishan
    Wu, Yibo
    Xiang, Shipei
    Luo, Yi
    Liu, Lizhen
    HLA, 2024, 103 (06)
  • [38] Post-transplant de novo non donor-specific HLA antibodies are not associated with poor graft outcome in non-sensitized pediatric recipients of kidney transplantation
    Cioni, Michela
    Comoli, Patrizia
    Tagliamacco, Augusto
    Innocente, Annalisa
    Basso, Sabrina
    Fontana, Iris
    Magnasco, Alberto
    Trivelli, Antonella
    Nocco, Angela
    Macchiagodena, Mario
    Catenacci, Laura
    Klersy, Catherine
    Verrina, Enrico
    Garibotto, Giacomo
    Ghiggeri, Gian Marco
    Cardillo, Massimo
    Ginevri, Fabrizio
    Nocera, Arcangelo
    TRANSPLANT IMMUNOLOGY, 2021, 65
  • [39] POST-TRANSPLANT DE NOVO ANTI-HLA DONOR SPECIFIC ANTIBODIES MAY CONTRIBUTE TO POOR GRAFT FUNCTION AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Ji, Xinyu
    Yang, Luxin
    Lai, Xiaoyu
    Ye, Yishan
    Wu, Yibo
    Xiang, Shipei
    Luo, Yi
    Liu, Lizhen
    BONE MARROW TRANSPLANTATION, 2024, 59 : 562 - 562
  • [40] Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis
    Maria Stepanova
    Linda Henry
    Rishi Garg
    Shirley Kalwaney
    Sammy Saab
    Zobair Younossi
    BMC Gastroenterology, 15
12345